Table 4.
EYA and human disease
| Disease | Gene | Type of misregulation | References |
|---|---|---|---|
| Branchiootorenal syndrome | EYA1 | Loss of function mutations | [87, 95] |
| Otofaciocervical syndrome | EYA1 | Loss of function mutations | [97] |
| Cardiofacial syndrome | EYA1 | Loss of function mutations | [107] |
| Congenital cataract | EYA1 | Loss of function mutations | [47] |
| Wilms’ tumor | EYA1 | Overexpression | [137] |
| EBV-negative gastric cancer | EYA1 | Frequent methylation | [138] |
| Late-onset deafness | EYA4 | Loss of function mutations | [99] |
| Dilated cardiomyopathy | EYA4 | Deletion | [106] |
| Esophageal adenocarcinoma | EYA4 | Frequent methylation (overexpression) | [128] |
| Colon cancer | EYA4 | Overexpression | [130] |
| Colorectal cancer | EYA4 | Overexpression | [131] |
| Colorectal cancer | EYA2 | Silencing methylation | [139] |
| Epithelial ovarian cancer | EYA2 | Overexpression | [133] |
| Lung adenocarcinoma | EYA2 | Overexpression | [134] |
| Pancreatic ductal adenocarcinoma | EYA3 | Frequent deletion | [140] |